Abiopharma

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors

Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025

Curaleaf Joins S&P/TSX Composite Index

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment

Cybin - Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder

Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder

A New Press Release from Oncolytics Biotech, Inc

Compugen - Compugen to Present Research at the Single Cell Genomics 2025 Conference

Ocular Therapeutix™ to Host Investor Day on September 30, 2025